会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明授权
    • Methods and systems for modulating medicants using acoustic energy
    • 使用声能调节药物的方法和系统
    • US09216276B2
    • 2015-12-22
    • US12116810
    • 2008-05-07
    • Michael H. SlaytonPeter G. BartheInder Raj S. Makin
    • Michael H. SlaytonPeter G. BartheInder Raj S. Makin
    • A61M37/00A61N7/00A61N7/02A61B19/00A61B8/00
    • A61M37/0092A61B8/4281A61B2090/378A61M2037/0007A61M2205/3375A61N7/00A61N7/02A61N2007/0008A61N2007/0043A61N2007/0056
    • This invention provides methods and systems uniquely capable of enhancing medicant delivery and/or effectiveness through the use of energy to predictably disrupt membranes and mechanically and thermally modulate cells and tissues. In exemplary embodiments, the methods and systems disclosed herein are capable of modulating multiple layers of tissue. In an exemplary embodiment, the energy is acoustic energy (e.g., ultrasound). In other exemplary embodiments, the energy is photon based energy (e.g., IPL, LED, laser, white light, etc.), or other energy forms, such radio frequency electric currents, or various combinations of acoustic energy, electromagnetic energy and other energy forms or energy absorbers such as cooling. Medicants can be first introduced to the region of interest by diffusion, circulation, and/or injection. An exemplary system for enhancing medicant delivery and/or effectiveness comprises a control system, a probe, and a display or indicator system. Imaging and/or monitoring may alternatively be coupled and/or co-housed with an ultrasound system contemplated by the present invention.
    • 本发明提供了能够通过使用能量来预测性地破坏膜并机械和热调节细胞和组织来增强药物递送和/或有效性的方法和系统。 在示例性实施例中,本文公开的方法和系统能够调制多层组织。 在示例性实施例中,能量是声能(例如,超声)。 在其它示例性实施例中,能量是基于光子的能量(例如,IPL,LED,激光,白光等)或其他能量形式,例如射频电流,或声能,电磁能和其他能量的各种组合 形式或能量吸收器如冷却。 首先通过扩散,循环和/或注射将药物引入感兴趣的区域。 用于增强药物递送和/或有效性的示例性系统包括控制系统,探针和显示器或指示器系统。 可以与本发明预期的超声系统可以联接和/或共同成像和/或监视。
    • 28. 发明申请
    • METHODS AND SYSTEMS FOR MODULATING MEDICANTS USING ACOUSTIC ENERGY
    • 使用声学能量调制药物的方法和系统
    • US20080281255A1
    • 2008-11-13
    • US12116810
    • 2008-05-07
    • Michael H. SlaytonPeter G. BartheInder Raj S. Makin
    • Michael H. SlaytonPeter G. BartheInder Raj S. Makin
    • A61N7/00
    • A61M37/0092A61B8/4281A61B2090/378A61M2037/0007A61M2205/3375A61N7/00A61N7/02A61N2007/0008A61N2007/0043A61N2007/0056
    • This invention provides methods and systems uniquely capable of enhancing medicant delivery and/or effectiveness through the use of energy to predictably disrupt membranes and mechanically and thermally modulate cells and tissues. In exemplary embodiments, the methods and systems disclosed herein are capable of modulating multiple layers of tissue. In an exemplary embodiment, the energy is acoustic energy (e.g., ultrasound). In other exemplary embodiments, the energy is photon based energy (e.g., IPL, LED, laser, white light, etc.), or other energy forms, such radio frequency electric currents, or various combinations of acoustic energy, electromagnetic energy and other energy forms or energy absorbers such as cooling. Medicants can be first introduced to the region of interest by diffusion, circulation, and/or injection. An exemplary system for enhancing medicant delivery and/or effectiveness comprises a control system, a probe, and a display or indicator system. Imaging and/or monitoring may alternatively be coupled and/or co-housed with an ultrasound system contemplated by the present invention.
    • 本发明提供了能够通过使用能量来预测性地破坏膜并机械和热调节细胞和组织来增强药物递送和/或有效性的方法和系统。 在示例性实施例中,本文公开的方法和系统能够调制多层组织。 在示例性实施例中,能量是声能(例如,超声)。 在其它示例性实施例中,能量是基于光子的能量(例如,IPL,LED,激光,白光等)或其他能量形式,例如射频电流,或声能,电磁能和其他能量的各种组合 形式或能量吸收器如冷却。 首先通过扩散,循环和/或注射将药物引入感兴趣的区域。 用于增强药物递送和/或有效性的示例性系统包括控制系统,探针和显示器或指示器系统。 可以与本发明预期的超声系统可以联接和/或共同成像和/或监视。
    • 29. 发明授权
    • Intra-cavitary ultrasound medical system and method
    • 腔内超声医疗系统及方法
    • US07247141B2
    • 2007-07-24
    • US10795680
    • 2004-03-08
    • Inder Raj S. MakinYoav AvidorMichael H. SlaytonPeter G. Barthe
    • Inder Raj S. MakinYoav AvidorMichael H. SlaytonPeter G. Barthe
    • A61B8/00
    • A61B17/42A61B8/12A61B8/445A61B8/4483A61B17/2202A61B2017/2253A61B2017/4216
    • A method for medically employing ultrasound within a body cavity of a patient. An end effector is obtained having a medical ultrasound transducer assembly. A biocompatible hygroscopic substance is obtained having a non-expanded anhydrous state and having an expanded and fluidly-loculated hydrated state. The end effector, including the transducer assembly, and the substance in substantially its anhydrous state are inserted into a body cavity (such as endoscopically inserted into a uterus) of a patient. The transducer assembly is used to medically image and/or medically treat patient tissue (such as stopping blood flow to, and/or ablating, a uterine fibroid). A system for medically employing ultrasound includes the end effector and the substance. In another system, the end effector includes the substance. The substance in its hydrated state expands inside the body cavity providing acoustic coupling between the wall of the body cavity and the transducer assembly.
    • 一种在患者体腔内医用超声波的方法。 获得具有医学超声换能器组件的端部执行器。 获得具有未膨胀无水状态并且具有膨胀和流动位置的水合状态的生物相容性吸湿性物质。 末端执行器(包括换能器组件)和基本上其无水状态的物质插入患者的体腔(例如内窥镜插入子宫中)。 换能器组件用于医疗图像和/或医学上治疗患者组织(例如阻止血液流向和/或消融子宫肌瘤)。 用于医学使用超声波的系统包括末端执行器和物质。 在另一系统中,末端执行器包括物质。 其水合状态的物质在体腔内扩张,提供体腔壁与换能器组件之间的声耦合。